An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the gnrh analogue goserelin in the long-term treatment of hirsutism

Gynecologic and Obstetric Investigation

Volumn 41, Issue 4, 1996, Pages 260-268

  Vegetti, Walter ^a   Testa, Giovanna ^a   Maggioni, Paola ^a   Motta, Tiziano ^a   Falsetti, Leopoldo ^b   Crosignani, Pier Giorgio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cyproterone acetate; Drug therapy; Ethinyl estradiol; Goserelin; Hirsutism; Oral contraceptive; Randomized trial

Indexed keywords

CYPROTERONE ACETATE; ETHINYLESTRADIOL; GOSERELIN; ORAL CONTRACEPTIVE AGENT;

ABDOMEN; ADULT; ANKLE EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FACE; FEMALE; HAIR GROWTH; HIRSUTISM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACNE VULGARIS; ADULT; CONTRACEPTIVES, ORAL; CYPROTERONE ACETATE; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GOSERELIN; HIRSUTISM; HUMANS; LUTEINIZING HORMONE; TESTOSTERONE;

EID: 0029970955     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000292281     Document Type: Article

References (30)

1. Maroulis GB: Evaluation of hirsutism and hy-perandrogenemia. Fertil Steril 1981:36:273-305.
2. Bonne C. Saurat JH. Chivot M. Lehuchet D, Raynaud JP: Androgen receptor in human skin. Br J Dermatol 1977:97:501-503.
3. Ferriman D. Gallwcy JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961:21:1440-1447.
4. Lorenzo EM: Familial study of hirsutism. J Clin Endocrinol Metab 1970:31:556-564.
5. Abraham GE. Maroulis GB, Buster JE, Chang RJ. Marshall JR: Effect of dexamcthasone or serum cortisol and androgen levels in hirsute patients. Obstct Gynecol 1976:47:395-402.
6. Barth JH: Hirsute women: Should they be investigated? ACP J Club 1992:131:188-192.
7. Match R. Rosenficld RL. Kim MH, Tredway D: Hirsutism: Implications, etiology, and management. Am J Obstet Gynecol 1981:140:815-830.
8. Ismail AAA, Davidson DW. Souka AR. Barnes EW. Irvine WJ. Kilimnik H. Vandcrbcekcn Y: The evaluation of the role of androgens in hirsutism and the use of a new antiandrogen cyprotcrone acetate for therapy. J Clin Endocrinol Metab 1974:39:81-95.
9. Hammerstein J. Meckies J. Lco-Rossberg I. Moltz L. Zielske F: Use of cyprotcrone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochcm 1975:6:827-836.
10. Barth JH. Cherry CA. Wojnarowska F, Dawbcr RPR: Cyprotcrone acetate for severe hirsutism: Results of a double-blind dose-ranging study. Clin Endocrinol 1991:35:5-10.
11. Ettingcr B. Goldficld EB. Burrill K.C. Von-Werder K. Forsham PH: Plasma testosterone stimulation suppression dynamics in hirsute women: Correlation with long-term therapy. Am J Med 1973:54:195-201.
12. Abraham GE. Maroulis GB. Boyers SP. Busier JE. Magyar DM. Eisner CW: Dexamethasonc suppression test in the management of hypcr-androgcnized patients to endocrine therapy. Obstet Gynecol 1981:57:158-165.
13. Casey JH, Burger HG. Kent JR. Kellie AE. Moxham A, Nabarro J. Nabarro JDN: Treatment of hirsutism by adrenal and ovarian suppression. J Clin Endocrinol 1966:26:1370-1374.
14. Givens JR. Andersen RN. Wiser WL, Umstot ES, Fish SA: The effectiveness of two oral contraceptives in suppressing plasma androstcne-dione. testosterone, LH. and FSH. and in stimulating plasma testosterone binding capacity in hirsute women. Am J Obstet Gynecol 1976: 124:333-339.
15. Ettinger B, Golditch IM: Medroxyprogesterone acetate for the evaluation of hypertestostero-nism in hirsute women. Fertil Steril 1977:28: 1285-1288.
16. Barth JH, Cherry CA. Wojnarowska F. Dawbcr RPR: Spironolactone is an effective and well tolerated systemic antiandrogen therapy for hirsute women. J Clin Endocrinol Metab 1989: 68:1-5.
17. Cumming DC, Yang JC. Rebar RW. Yen SSC: Treatment of hirsutism with spironolactone. JAMA 1982;247:1295-1298.
18. Akalin S: Effects of ketoconazole in hirsute women. Acta Endocrinol 1991:124:19-22.
19. Motta T. Maggi G, Pet ra M, Azzolari E. Casaz-za S. D'Alberton A: Flutantide in the treatment of hirsutism. Int J Gynecol Obstet 1991:36: 155-157.
20. Marcondcs JAM. Minnani SL. Luthold WW. Wajchenberg BL. Samojlik E. Kirschner MA: Treatment of hirsutism in women with fluta-midc. Fertil Steril 1992:57:543-547.
21. Vigersky RA. Mehlntan I, Glass AR. Smith CE: Treatment of hirsute women with cimetidine: A preliminary' report. N Engl J Med 1980:303: 1042.
22. Puri V. Puri CP. Anand Kumar TC: Serum levels of dihvdrotestostcrone in male rhesus monkeys estimated by a non-chromatographic radioimmunoassay method. J Steroid Biochem 1981:14:877-881.
23. Berry DA. Eaton ML, Ekholm BP. Fox TL: Assessing differential drug effect. Biometrics 1984:40:1109-1115.
24. Rushlon DH. Ramsay ID. James KC. Norris MJ, Gilkes JJH: Biochemical and trichological characterization of diffuse alopecia in women. BrJ Dermatol 1990:123:187-197.
25. Andreyko JL. Monroe SE. Jaffe RB: Treatment of hirsutism w ith a gonadotropin releasing hormone agonist (nafarclin). J Clin Endocrinol Metab 1986:63:854-859.
26. Rittmaster RS. Thompson DL: Effect of leu-prolide and dcxamethasone on hair growth and hormone levels in hirsute women: The relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 1990:70:1096-1102.
27. Rademaker M. Simpson NB. Gudmundsson J. Bonduelle M. Fleming R, Coutts JRT: Effect of the gonadotropin releasing hormone analogue, goserelin, and ocstradiol replacement on sebum excretion rates and hair size in mildly hirsute women. J Dermatol Treat 1991; 1:289-292.
28. Van cer Spuy ZM. Nugent FA. Mahabeer S: The management of hyperandrogenism with GnRH agonist therapy. Br J Obstet Gynaecol 1991:98:497.
29. Falsetti L, Pasinetti E: Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism. Fer-til Steril 1994:61:817-822.
30. Simberg M. Tiitinen A. Stenman U-H. Ylikor-kala O: Long acting GnRH-agonist (Zoladex depot) combined with estrogen add back therapy in treatment of ovarian hirsutism. Int J Gynecol Obstet 1991:36:123.